Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term ASSOCIATION. Found 13 abstracts

Handorf E, Crumpler N, Gross L, Giri VN. Prevalence of the HOXB13 G84E Mutation Among Unaffected Men with a Family History of Prostate Cancer. Journal of Genetic Counseling. 2014 Jun;23(3):371-6.   PMCID: PMC4028414
Ciocca V, Daskalakis C, Ciocca RM, Ruiz-Orrico A, Palazzo JP. The significance of GATA3 expression in breast cancer: a 10-year follow-up study. Human Pathology. 2009 Apr;40(4):489-95.
Che M, Desilvio M, Pollack A, Grignon DJ, Mohan Venkatesan V, Hanks GE, Sandler HM. Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: A study based on RTOG 9202. International Journal of Radiation Oncology Biology Physics. 2007 Nov;69(4):1117-23.
Egleston BL, Scharfstein DO, Freeman EE, West SK. Causal inference for non-mortality outcomes in the presence of death. Biostatistics. 2007 Jul;8(3):526-45.
Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. New England Journal of Medicine. 2007 Dec;357(25):2552-61.
Rebbeck TR, Troxel AB, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Norman S, Bunin G, DeMichele A, Berlin M, Schinnar R, Berlin JA, Strom BL. Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiology Biomarkers & Prevention. 2007 Mar;16(3):444-50.
Roach M, De Silvio M, Rebbick T, Grignon D, Rotman M, Wolkov H, Fisher B, Hanks G, Shipley WU, Pollack A, Sandler H, Watkins-Bruner D. Racial differences in cyp3a4 genotype and survival among men treated on radiation therapy oncology group (rtog) 9202: A phase III randomized trial. International Journal of Radiation Oncology Biology Physics. 2007 Sep;69(1):79-87.
Sauter ER, Ganz PA, Ehya H, Hewett JE, Schlatter L, Kliethermes B, Daly MB. Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs. Breast. 2007 Oct;16(5):489-94.
Brown T, Sigurdson E, Rogatko A, Broccoli D. Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line. Annals of Surgical Oncology. 2003 Oct;10(8):910-5.
De Vita G, Melillo RM, Carlomagno F, Visconti R, Castellone MD, Bellacosa A, Billaud M, Fusco A, Tsichlis PN, Santoro M. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Research. 2000 Jul;60(14):3727-31.
Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proceedings of the National Academy of Sciences of the United States of America. 1997 Apr;94(8):3627-32.
Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM, Vogt PK. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (New York, NY). 1997 Jun;276(5320):1848-50.
Hohaus S, Cavallo S, Bellacosa A, Genuardi M, Galli J, Cadoni G, Almadori G, Lauriola L, Litwin S, Maurizi M, Neri G. Telomerase activity in human laryngeal squamous cell carcinomas. Clinical Cancer Research. 1996 Nov;2(11):1895-900.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term ASSOCIATION

ASSOCIATION GENE ACTIVATION RISK SMOKING EXPRESSION MUTATIONS REGULATOR HUMAN BREAST-CANCER HUMAN-PAPILLOMAVIRUS LONG emotional distress TARGET DEPRESSIVE SYMPTOMS IL-2 RECEPTOR TOXICITY DOCKING SITE GENETIC POLYMORPHISMS Immunohistochemistry POLYMORPHISMS Genetics & Heredity Locally PHOSPHATIDYLINOSITOL 3-KINASE PTC2 C-AKT HIV VACCINE TRIALS HORMONE REPLACEMENT THERAPY BCL-2 PROGNOSIS SHC FLUOROURACIL ENDOMETRIAL CANCER HOXB13 MODEL INDEPENDENT MECHANISMS BREAST-CANCER WOMEN MAMMARY-GLAND AVIAN-SARCOMA SUSCEPTIBILITY REGION PROTEIN-KINASE P53 NETWORK LOCALIZATION VIRAL LOAD telomerase p53 VISUAL IMPAIRMENT FOLLOW-UP ESTROGEN-RECEPTOR analysis ALCOHOL RESISTANCE PROTOONCOGENE LENGTH sensitivity ELDERLY PEOPLE CYTOLOGY breast cancer detection LIFE-SPAN CARCINOMA vision loss GENETIC VARIANT SENSITIVITY RADIATION-THERAPY OVEREXPRESSION P53 GENE Genetic mutations LEUCOVORIN Breast cancer GATA3-Tamoxifen CLINICAL PRESENTATION MELANOMA-CELLS DIFFERENTIATION KeyWords Plus: BINDING STIMULATION POPULATION GERMLINE MUTATIONS INCREASED RISK RTOG 9202 SECRETION ADENOCARCINOMA TOBACCO CELLS Androgen deprivation and radiotherapy PROSTATE-CANCER ZIDOVUDINE MUTATION NECK-CANCER CARRIERS race DOMAIN HT-29 colon cancer cell line radiotherapy Prostate cancer NIPPLE ASPIRATE FLUID BRCA1 RAS CANCER RISK STRATIFICATION RADIOTHERAPY STAR FUNCTIONAL POLYMORPHISM RET PRINCIPAL nipple aspirate fluid OLDER-ADULTS genetic polymorphisms NUCLEAR ACCUMULATION competing risk PHOSPHATIDYLINOSITOL KINASE-ACTIVITY RECEPTOR BETA-CHAIN AZT FAMILY VIRUS HAPLOTYPES PROTEIN POPULATION STRATIFICATION ONCOGENE IMMUNOREACTIVITY Family history CYTOCHROME P4501B1 TUMORS Prognostic factor LOCI telomere NERVE GROWTH-FACTOR advanced prostate cancer causal inference prostate cancer HEAD PHOSPHOINOSITIDE 3-KINASE
Last updated on Friday, January 03, 2020